MarginsXMarginsX
Home › Markets › Health Care › SLBT

SL Science Holding Limited (SLBT)

SLBT trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.7195
-3.42% on the day
Market cap
$403.5M
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerSLBT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CountryTaiwan
IPO yearNot reported by the screener
SEC CIK0002070534
SEC industry codeBiological Products, (No Diagnostic Substances)
Incorporated inCayman Islands

Financials

New registrant: no annual report filed under this company yet.

Warning signs

Cash runway
no XBRL financials
Share count, 1 year
No year-earlier count
Going-concern doubt
Yes
20-F filed June 18, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about its ability to continue as a going concern."
20-F 2026-06-18
Cash and burnno XBRL financialsNone on EDGAR
Shares outstandingNo cover-page share count in XBRLNone on EDGAR
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorARK PRO CPA & CO, Hong Kong, ChinaPCAOB Form AP 2026-07-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-08-14
Latest annual report
ANNUAL REPORT
20-F2026-06-18
Latest quarterly / interim
FORM 6-K
6-K2026-11-03

Source: SEC EDGAR submissions feed, 45 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-22.5%
1 month-52.5%
3 months-73.2%
Year to date-93.1%
1 year-93.0%
From 52-week high-94.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Biological Products (No Diagnostic Substances)

TickerCompanyPriceDayMarket cap
IRLAIRulya Therapeutics Inc.$37.36-6.13%$405.0M
TECXTectonic Therapeutic Inc.$20.98-0.76%$418.5M
TVGNTevogen Inc.$6.22+3.67%$422.2M
ALECAlector Inc.$2.57+1.18%$382.6M
FENCFennec Pharmaceuticals Inc.$12.76+9.81%$450.5M
CADLCandel Therapeutics Inc.$5.81-6.29%$455.8M
CCCCC4 Therapeutics Inc.$2.65-3.99%$348.0M
RGNXREGENXBIO Inc.$7.32-4.19%$484.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier